- Home
- AVIR vs WBX Comparison
AVIR vs WBX Comparison
Compare AVIR & WBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- WBX
- Stock Information
- Founded
- AVIR 2012
- WBX 2015
- Country
- AVIR United States
- WBX Spain
- Employees
- AVIR N/A
- WBX N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- WBX Industrial Specialties
- Sector
- AVIR Health Care
- WBX Consumer Discretionary
- Exchange
- AVIR Nasdaq
- WBX Nasdaq
- Market Cap
- AVIR 276.9M
- WBX 293.9M
- IPO Year
- AVIR 2020
- WBX N/A
- Fundamental
- Price
- AVIR $3.25
- WBX $0.68
- Analyst Decision
- AVIR Hold
- WBX Buy
- Analyst Count
- AVIR 1
- WBX 3
- Target Price
- AVIR $6.88
- WBX $1.42
- AVG Volume (30 Days)
- AVIR 178.7K
- WBX 632.0K
- Earning Date
- AVIR 11-07-2024
- WBX 11-06-2024
- Dividend Yield
- AVIR N/A
- WBX N/A
- EPS Growth
- AVIR N/A
- WBX N/A
- EPS
- AVIR N/A
- WBX N/A
- Revenue
- AVIR N/A
- WBX $179,622,844.00
- Revenue This Year
- AVIR N/A
- WBX $25.52
- Revenue Next Year
- AVIR N/A
- WBX $26.83
- P/E Ratio
- AVIR N/A
- WBX N/A
- Revenue Growth
- AVIR N/A
- WBX 16.10
- 52 Week Low
- AVIR $2.81
- WBX $0.50
- 52 Week High
- AVIR $4.60
- WBX $2.09
- Technical
- Relative Strength Index (RSI)
- AVIR 44.03
- WBX 33.13
- Support Level
- AVIR $3.10
- WBX $0.50
- Resistance Level
- AVIR $3.48
- WBX $1.06
- Average True Range (ATR)
- AVIR 0.13
- WBX 0.08
- MACD
- AVIR -0.01
- WBX -0.02
- Stochastic Oscillator
- AVIR 29.52
- WBX 31.59
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.